Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024583309> ?p ?o ?g. }
- W2024583309 endingPage "511" @default.
- W2024583309 startingPage "502" @default.
- W2024583309 abstract "Neoadjuvant chemotherapy plus radiotherapy is the most common treatment regimen for advanced nasopharyngeal carcinoma (NPC). Whether chronomodulated infusion of chemotherapy can reduce its toxicity is unclear. This study aimed to evaluate the toxic and therapeutic effects of sinusoidal chronomodulated infusion versus flat intermittent infusion of cisplatin (DDP) and 5-fluorouracil (5-FU) followed by radiotherapy in patients with locoregionally advanced NPC. Patients with biopsy-diagnosed untreated stages III and IV NPC (according to the 2002 UICC staging system) were randomized to undergo 2 cycles of sinusoidal chronomodulated infusion (Arm A) or flat intermittent constant rate infusion (Arm B) of DDP and 5-FU followed by radical radiotherapy. Using a MELODIE multi-channel programmed pump, the patients were given 12-hour continuous infusions of DDP (20 mg/m2) and 5-FU (750 mg/m2) for 5 days, repeated every 3 weeks for 2 cycles. DDP was administered from 10:00 am to 10:00 pm, and 5-FU was administered from 10:00 pm to 10:00 am each day. Chronomodulated infusion was performed in Arm A, with the peak deliveries of 5-FU at 4:00 am and DDP at 4:00 pm. The patients in Arm B underwent a constant rate of infusion. Radiotherapy was initiated in the fifth week, and both arms were treated with the same radiotherapy techniques and dose fractions. Between June 2004 and June 2006, 125 patients were registered, and 124 were eligible for analysis of response and toxicity. The major toxicity observed during neoadjuvant chemotherapy was neutropenia. The incidence of acute toxicity was similar in both arms. During radiotherapy, the incidence of stomatitis was significantly lower in Arm A than in Arm B (38.1% vs. 59.0%, P = 0.020). No significant differences were observed for other toxicities. The 1-, 3-, and 5-year overall survival rates were 88.9%, 82.4%, and 74.8% for Arm A and 91.8%, 90.2%, and 82.1% for Arm B. The 1-, 3-, and 5-year progression-free survival rates were 91.7%, 88.1%, and 85.2% for Arm A and 100%, 94.5%, and 86.9% for Arm B. The 1-, 3-, and 5-year distant metastasis-free survival rates were 82.5%, 79.1%, and 79.1% for Arm A and 90.2%, 85.2%, and 81.7% for Arm B. Chronochemotherapy significantly reduced stomatitis but was not superior to standard chemotherapy in terms of hematologic toxicities and therapeutic response." @default.
- W2024583309 created "2016-06-24" @default.
- W2024583309 creator A5027044275 @default.
- W2024583309 creator A5037798401 @default.
- W2024583309 creator A5040776138 @default.
- W2024583309 creator A5048052584 @default.
- W2024583309 creator A5056646576 @default.
- W2024583309 creator A5061152137 @default.
- W2024583309 creator A5061479503 @default.
- W2024583309 creator A5074169809 @default.
- W2024583309 creator A5074174608 @default.
- W2024583309 creator A5081700896 @default.
- W2024583309 creator A5084047711 @default.
- W2024583309 creator A5085762574 @default.
- W2024583309 date "2013-09-05" @default.
- W2024583309 modified "2023-09-23" @default.
- W2024583309 title "Randomized study of sinusoidal chronomodulated versus flat intermittent induction chemotherapy with cisplatin and 5-fluorouracil followed by traditional radiotherapy for locoregionally advanced nasopharyngeal carcinoma" @default.
- W2024583309 cites W174811765 @default.
- W2024583309 cites W1902822116 @default.
- W2024583309 cites W1916546429 @default.
- W2024583309 cites W1970541895 @default.
- W2024583309 cites W1976661936 @default.
- W2024583309 cites W1984396523 @default.
- W2024583309 cites W2005374110 @default.
- W2024583309 cites W2026063001 @default.
- W2024583309 cites W2051367322 @default.
- W2024583309 cites W2076668534 @default.
- W2024583309 cites W2094337557 @default.
- W2024583309 cites W2116297115 @default.
- W2024583309 cites W2120308976 @default.
- W2024583309 cites W2125919881 @default.
- W2024583309 cites W2127706390 @default.
- W2024583309 cites W2131589968 @default.
- W2024583309 cites W2368695350 @default.
- W2024583309 cites W2379314846 @default.
- W2024583309 cites W3191734867 @default.
- W2024583309 doi "https://doi.org/10.5732/cjc.013.10004" @default.
- W2024583309 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3845560" @default.
- W2024583309 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23816561" @default.
- W2024583309 hasPublicationYear "2013" @default.
- W2024583309 type Work @default.
- W2024583309 sameAs 2024583309 @default.
- W2024583309 citedByCount "19" @default.
- W2024583309 countsByYear W20245833092015 @default.
- W2024583309 countsByYear W20245833092016 @default.
- W2024583309 countsByYear W20245833092017 @default.
- W2024583309 countsByYear W20245833092018 @default.
- W2024583309 countsByYear W20245833092019 @default.
- W2024583309 countsByYear W20245833092020 @default.
- W2024583309 countsByYear W20245833092021 @default.
- W2024583309 countsByYear W20245833092022 @default.
- W2024583309 countsByYear W20245833092023 @default.
- W2024583309 crossrefType "journal-article" @default.
- W2024583309 hasAuthorship W2024583309A5027044275 @default.
- W2024583309 hasAuthorship W2024583309A5037798401 @default.
- W2024583309 hasAuthorship W2024583309A5040776138 @default.
- W2024583309 hasAuthorship W2024583309A5048052584 @default.
- W2024583309 hasAuthorship W2024583309A5056646576 @default.
- W2024583309 hasAuthorship W2024583309A5061152137 @default.
- W2024583309 hasAuthorship W2024583309A5061479503 @default.
- W2024583309 hasAuthorship W2024583309A5074169809 @default.
- W2024583309 hasAuthorship W2024583309A5074174608 @default.
- W2024583309 hasAuthorship W2024583309A5081700896 @default.
- W2024583309 hasAuthorship W2024583309A5084047711 @default.
- W2024583309 hasAuthorship W2024583309A5085762574 @default.
- W2024583309 hasBestOaLocation W20245833091 @default.
- W2024583309 hasConcept C126322002 @default.
- W2024583309 hasConcept C126894567 @default.
- W2024583309 hasConcept C141071460 @default.
- W2024583309 hasConcept C143998085 @default.
- W2024583309 hasConcept C2776694085 @default.
- W2024583309 hasConcept C2777063308 @default.
- W2024583309 hasConcept C2778239845 @default.
- W2024583309 hasConcept C2778496288 @default.
- W2024583309 hasConcept C2778997737 @default.
- W2024583309 hasConcept C2780456651 @default.
- W2024583309 hasConcept C2781413609 @default.
- W2024583309 hasConcept C29730261 @default.
- W2024583309 hasConcept C509974204 @default.
- W2024583309 hasConcept C71924100 @default.
- W2024583309 hasConceptScore W2024583309C126322002 @default.
- W2024583309 hasConceptScore W2024583309C126894567 @default.
- W2024583309 hasConceptScore W2024583309C141071460 @default.
- W2024583309 hasConceptScore W2024583309C143998085 @default.
- W2024583309 hasConceptScore W2024583309C2776694085 @default.
- W2024583309 hasConceptScore W2024583309C2777063308 @default.
- W2024583309 hasConceptScore W2024583309C2778239845 @default.
- W2024583309 hasConceptScore W2024583309C2778496288 @default.
- W2024583309 hasConceptScore W2024583309C2778997737 @default.
- W2024583309 hasConceptScore W2024583309C2780456651 @default.
- W2024583309 hasConceptScore W2024583309C2781413609 @default.
- W2024583309 hasConceptScore W2024583309C29730261 @default.
- W2024583309 hasConceptScore W2024583309C509974204 @default.
- W2024583309 hasConceptScore W2024583309C71924100 @default.
- W2024583309 hasIssue "9" @default.
- W2024583309 hasLocation W20245833091 @default.
- W2024583309 hasLocation W20245833092 @default.
- W2024583309 hasLocation W20245833093 @default.